Arcutis Biotherapeutics (ARQT) Inventory Average (2022 - 2025)
Historic Inventory Average for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $19.4 million.
- Arcutis Biotherapeutics' Inventory Average rose 3888.87% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 3888.87%. This contributed to the annual value of $13.8 million for FY2024, which is 3395.97% up from last year.
- Latest data reveals that Arcutis Biotherapeutics reported Inventory Average of $19.4 million as of Q3 2025, which was up 3888.87% from $16.5 million recorded in Q2 2025.
- Arcutis Biotherapeutics' Inventory Average's 5-year high stood at $19.4 million during Q3 2025, with a 5-year trough of $5.9 million in Q4 2022.
- In the last 4 years, Arcutis Biotherapeutics' Inventory Average had a median value of $13.5 million in 2023 and averaged $13.0 million.
- Per our database at Business Quant, Arcutis Biotherapeutics' Inventory Average surged by 12880.47% in 2023 and then surged by 552.37% in 2024.
- Quarter analysis of 4 years shows Arcutis Biotherapeutics' Inventory Average stood at $5.9 million in 2022, then surged by 128.8% to $13.5 million in 2023, then grew by 5.52% to $14.3 million in 2024, then soared by 35.75% to $19.4 million in 2025.
- Its last three reported values are $19.4 million in Q3 2025, $16.5 million for Q2 2025, and $15.6 million during Q1 2025.